# SRTD Biotech

**Source:** https://www.startuphub.ai/startups/srtd-biotech
**Profile type:** Startup

> SRTD Biotech develops next-generation precision mRNA therapeutics targeting diseased cells.

## About

Founded in 2019, SRTD Biotech is an integrated RNA therapeutics company focused on developing cell-specific messenger RNA (mRNA) therapies. Its platform combines proprietary selectively expressed RNA (seRNA) technology, a novel fusogenic LNP delivery platform, and a synthetic biology platform with bioinformatics and AI-driven RNA design capabilities to achieve precise, selective therapeutic activity within target cells while limiting exposure in healthy tissue.

## Key facts

- **Slug:** srtd-biotech
- **Website:** https://srtd-biotech.com
- **Location:** Jülich, Germany
- **Founded:** 2019-01-01
- **Operating status:** Active
- **Total funding:** $34M
- **Sectors / tags:** Biotechnology, Therapeutics, Life Sciences

## StartupHub.ai scores

- **Ahrefs DR:** 4/100
- **Agent Readiness:** D (50/100)
- **Site Speed:** 61/100
- **Data Trust:** 72/100

## Funding rounds

| Date | Round | Amount | Lead investors |
| --- | --- | --- | --- |
| 1 Nov 2026 | [Seed](https://www.startuphub.ai/investment_rounds/srtd-biotech-seed-2026) | $34M | [Mérieux Equity Partners (via OMX Europe Venture Fund)](https://www.startuphub.ai/investors/merieux-equity-partners-via-omx-europe-venture-fund), [NRW.BANK](https://www.startuphub.ai/investors/nrw-bank), [Boehringer Ingelheim Venture Fund (BIVF)](https://www.startuphub.ai/investors/boehringer-ingelheim-venture-fund-bivf) |

## Tech stack

Detected on srtd-biotech.com, last scanned 2026-11-09.

- **Email provider:** Microsoft 365

## JSON-LD

Structured data aligned with this page's `<script type="application/ld+json">` (included when the profile is server-rendered).

```json
{
  "@context": "https://schema.org",
  "@graph": [
    {
      "@type": "BreadcrumbList",
      "itemListElement": [
        {
          "@type": "ListItem",
          "position": 1,
          "name": "Home",
          "item": "https://www.startuphub.ai"
        },
        {
          "@type": "ListItem",
          "position": 2,
          "name": "Startups",
          "item": "https://www.startuphub.ai/startups"
        },
        {
          "@type": "ListItem",
          "position": 3,
          "name": "SRTD Biotech",
          "item": "https://www.startuphub.ai/startups/srtd-biotech"
        }
      ]
    },
    {
      "@type": "ProfilePage",
      "@id": "https://www.startuphub.ai/startups/srtd-biotech#webpage",
      "url": "https://www.startuphub.ai/startups/srtd-biotech",
      "name": "SRTD Biotech - AI Startup Profile | StartupHub.ai",
      "description": "This is the StartupHub.ai profile of SRTD Biotech. SRTD Biotech is a startup founded in 2019, operating in Biotechnology and Therapeutics. SRTD Biotech develops next-generation precision mRNA therapeutics targeting diseased cells. Headquartered in Jülich, Germany.",
      "dateModified": "2026-11-09T12:50:25.202Z",
      "mainEntity": {
        "@type": "Organization",
        "@id": "https://www.startuphub.ai/startups/srtd-biotech#organization"
      }
    },
    {
      "@type": "Organization",
      "@id": "https://www.startuphub.ai/startups/srtd-biotech#organization",
      "name": "SRTD Biotech",
      "url": "https://srtd-biotech.com",
      "logo": "https://cdn.startuphub.ai/storage/v1/object/public/entity-images/logos/4dec144f-4cb4-420a-b435-0eaff728c499-square.webp",
      "image": "https://cdn.startuphub.ai/storage/v1/object/public/entity-images/logos/4dec144f-4cb4-420a-b435-0eaff728c499-square.webp",
      "description": "Founded in 2019, SRTD Biotech is an integrated RNA therapeutics company focused on developing cell-specific messenger RNA (mRNA) therapies. Its platform combines proprietary selectively expressed RNA (seRNA) technology, a novel fusogenic LNP delivery platform, and a synthetic biology platform with bioinformatics and AI-driven RNA design capabilities to achieve precise, selective therapeutic activity within target cells while limiting exposure in healthy tissue.",
      "foundingDate": "2019-01-01",
      "address": {
        "@type": "PostalAddress",
        "addressLocality": "Jülich",
        "addressCountry": "Germany"
      },
      "knowsAbout": [
        "Biotechnology",
        "Therapeutics",
        "Life Sciences"
      ]
    }
  ]
}
```